Mastering the future of PCI with drug-coated balloons

Sponsored by B.Braun Melsungen AG

Anchorperson: R. Byrne

Spokesperson: B. Scheller

Summary

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB and explore new directions in managing de novo disease. Analyze the application of DCBs in chronic total occlusions (CTO) as part of a modern hybrid approach. Investigate the use of DCBs in multivessel and diffuse disease settings. Analyze real-world evidence showcasing their potential to minimize trauma and maximize outcomes. Additionally, explore the challenges and advancements in using DCBs for calcified lesions.

Learning Objectives

To receive the latest clinical insights into the available data for DCB usage in de-novo lesions
To learn about practical experiences on DCB in large vessels, bifurcations, multivessel disease and CTO
To get an understanding on how to use the hybrid approach especially for challenging lesions to improve clinical outcome